Its researchers noticed that during his interview Dr. Bourla had made statements about Covid and the use of Covid vaccines in children that were misleading, unbalanced and not capable of substantiation. They took these concerns to the U.K. regulatory body, the Prescription Medicines Code of Practice Authority (the PMCPA), and a recent article in the Telegraph reports that the PMCPA agreed with them.
Those of you shocked by the revelation that the MHRA is 86% funded by the pharmaceutical industry, prepare yourselves: because the PMCPA is 100% funded by the pharmaceutical industry. It also reports to the board of its industry body, the Association of the British Pharmaceutical Industry (the ABPI). This Board is mostly comprised of senior management of U.K. pharmaceutical companies. In fact, at the time this complaint about Pfizer was made, the President of the ABPI Board was also head of Pfizer in the U.K., and the current ABPI Vice-President is the Pfizer U.K. Country President. The PMCPA actually describes itself as “a division of the ABPI”. So, no potential conflicts of interest there then.